Status: current, Defined. Date: 30-Sep 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4180501000168119 | Ogivri (inert substance) diluent [1 x 20 mL vial] (&) (trastuzumab 440 mg) powder for injection [1 x 440 mg vial], 1 pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4180511000168116 | Ogivri (1 x 440 mg vial, 1 x 20 mL inert diluent vial), 1 pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ogivri (1 x 440 mg vial, 1 x 20 mL inert diluent vial), 1 pack | Is a | Ogivri (1 x 440 mg vial, 1 x 20 mL inert diluent vial), 1 pack | true | Inferred relationship | Some | ||
| Ogivri (1 x 440 mg vial, 1 x 20 mL inert diluent vial), 1 pack | Is a | containered trade product pack | false | Inferred relationship | Some | ||
| Ogivri (1 x 440 mg vial, 1 x 20 mL inert diluent vial), 1 pack | has TPUU | Ogivri (trastuzumab 440 mg) powder for injection, 440 mg vial | true | Inferred relationship | Some | 1 | |
| Ogivri (1 x 440 mg vial, 1 x 20 mL inert diluent vial), 1 pack | has TPUU | Ogivri (inert substance) diluent, 20 mL vial | true | Inferred relationship | Some | 2 | |
| Ogivri (1 x 440 mg vial, 1 x 20 mL inert diluent vial), 1 pack | has container type | pack | true | Inferred relationship | Some | ||
| Ogivri (1 x 440 mg vial, 1 x 20 mL inert diluent vial), 1 pack | has TP | Ogivri | true | Inferred relationship | Some | ||
| Ogivri (1 x 440 mg vial, 1 x 20 mL inert diluent vial), 1 pack | Is a | containered trade product pack | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR